• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utility of Lymph Node Ratio in Predicting Biochemical Incomplete Clinical Response in Patients with Papillary Ca thyroid with Positive Neck Node.淋巴结比率在预测颈部淋巴结阳性的甲状腺乳头状癌患者生化不完全临床反应中的应用
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4043-4049. doi: 10.1007/s12070-024-04777-7. Epub 2024 Jun 6.
2
Comparison of total thyroidectomy and lobectomy for intermediate-risk papillary thyroid carcinoma with lateral lymph node metastasis: a systematic review and meta-analysis.全甲状腺切除术与甲状腺叶切除术治疗伴有侧方淋巴结转移的中危乳头状甲状腺癌的比较:一项系统评价和荟萃分析
Int J Surg. 2025 Jun 25. doi: 10.1097/JS9.0000000000002673.
3
Central neck dissection for papillary thyroid cancer.甲状腺乳头状癌中央区淋巴结清扫术。
Cancer Control. 2011 Apr;18(2):83-8. doi: 10.1177/107327481101800202.
4
Multicenter analysis of radioactive iodine therapy outcomes after total thyroidectomy for T1-T2 stage papillary thyroid carcinoma with cervical lymph node metastasis in China.中国T1-T2期伴颈部淋巴结转移的乳头状甲状腺癌全甲状腺切除术后放射性碘治疗效果的多中心分析
Int J Surg. 2025 Jun 30. doi: 10.1097/JS9.0000000000002838.
5
Efficacy assessment of repeat iodine-131 treatment in patients with papillary thyroid carcinoma assessed as biochemical incomplete response.对评估为生化不完全缓解的甲状腺乳头状癌患者进行重复碘-131治疗的疗效评估
Endocrine. 2025 Apr 20. doi: 10.1007/s12020-025-04232-9.
6
Prediction of contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma based on radiomics.基于影像组学预测单侧甲状腺乳头状癌对侧中央区淋巴结转移
Sci Rep. 2025 Jul 1;15(1):21948. doi: 10.1038/s41598-025-04588-y.
7
Prognosis and Postoperative Complications of Wide-Field Isthmusectomy for Node-Negative Papillary Thyroid Carcinoma Limited to the Isthmus.局限于峡部的淋巴结阴性乳头状甲状腺癌行宽视野峡部切除术的预后及术后并发症
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251348423. doi: 10.1177/19160216251348423. Epub 2025 Jun 25.
8
Treatment Outcomes and Patterns of Disease Recurrence of Patients with Carcinoma of the Buccal Mucosa.颊黏膜癌患者的治疗结果与疾病复发模式
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5209-5220. doi: 10.1007/s12070-024-04948-6. Epub 2024 Aug 30.
9
Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.病理性转移性淋巴结密度(ND)可预测甲状腺乳头状癌患者根治性切除术后的早期复发。
Gland Surg. 2025 May 30;14(5):897-911. doi: 10.21037/gs-2025-36. Epub 2025 May 15.
10
Predicting the Unexpected: Clinicopathological Insights into Skip Metastasis in Papillary Thyroid Carcinoma.预测意外情况:甲状腺乳头状癌跳跃转移的临床病理见解
J Clin Med. 2025 Jun 15;14(12):4255. doi: 10.3390/jcm14124255.

本文引用的文献

1
Validation of ATA guidelines for Indian population: Do ATA guidelines have an impact on management of DTC patients in Indian population - A 5 year retrospective cohort analysis.
Oral Oncol. 2022 Sep;132:106016. doi: 10.1016/j.oraloncology.2022.106016. Epub 2022 Jul 8.
2
Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes.对于可触及淋巴结的病理阳性侧颈部淋巴结的甲状腺乳头状癌患者,转移性侧颈部淋巴结比例对复发的预测价值。
Head Neck. 2022 Jul;44(7):1623-1630. doi: 10.1002/hed.27067. Epub 2022 Apr 22.
3
Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.在预测甲状腺乳头状癌复发方面,淋巴结比率优于美国癌症联合委员会(AJCC)的N分期。
Endocr Connect. 2022 Feb 16;11(2):e210518. doi: 10.1530/EC-21-0518.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Association of Lymph Node Ratio With Overall Survival in Patients With Metastatic Papillary Thyroid Cancer.淋巴结比率与转移性甲状腺乳头状癌患者总生存的关联。
JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):962-964. doi: 10.1001/jamaoto.2020.2053.
6
Performance of ATA Risk Stratification Systems, Response to Therapy, and Outcome in an Indian Cohort of Differentiated Thyroid Carcinoma Patients: A Retrospective Study.印度分化型甲状腺癌患者队列中ATA风险分层系统的性能、对治疗的反应及结局:一项回顾性研究
Eur Thyroid J. 2019 Dec;8(6):312-318. doi: 10.1159/000500773. Epub 2019 Jun 26.
7
India launches plan for national cancer screening programme.印度启动国家癌症筛查计划。
BMJ. 2016 Oct 17;355:i5574. doi: 10.1136/bmj.i5574.
8
Nodal metastases in thyroid cancer: prognostic implications and management.甲状腺癌的淋巴结转移:预后意义及处理
Future Oncol. 2016 Apr;12(7):981-94. doi: 10.2217/fon.16.10. Epub 2016 Mar 7.
9
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
10
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.对于年龄小于 45 岁的甲状腺乳头状癌患者,淋巴结转移的存在和数量与生存受损有关。
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.

淋巴结比率在预测颈部淋巴结阳性的甲状腺乳头状癌患者生化不完全临床反应中的应用

Utility of Lymph Node Ratio in Predicting Biochemical Incomplete Clinical Response in Patients with Papillary Ca thyroid with Positive Neck Node.

作者信息

Gontu Gopi Satya Sai Reddy, Das Rajjyoti, Rahman Tashnin, Das Ashok Kumar, Das Kishore, Das Anupam, Kakati Kaberi

机构信息

Department of Head & Neck Surgery, Dr Bhubneshwar Borooah Cancer Institute Guwahati, Guwahati, Assam India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4043-4049. doi: 10.1007/s12070-024-04777-7. Epub 2024 Jun 6.

DOI:10.1007/s12070-024-04777-7
PMID:39376454
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11455996/
Abstract

BACKGROUND

with the requirement of aggressive follow-up in patients with biochemically incomplete response in patients of papillary ca. thyroid with neck node, a predictor for clinical response would be of great help for better treatment and follow-up planning.

AIM

To determine the utility of lymph-node ratio (central and lateral) as predictors for clinical response post total thyroidectomy and neck dissection.

MATERIALS AND METHODS

51 patients of papillary carcinoma thyroid with neck node were treated with surgery and RAI as per ATA guidelines and were analyzed for a median of 3 years. (Retrospective cohort analysis).

RESULTS

We did response evaluation, correlated clinical response with lymph-node ratios. We found a statistically significant relationship of lymph-node ratio with around a sensitivity and specificity of approximately 90% in predicting the biochemically incomplete response.

CONCLUSION

we conclude that lateral and central compartment ratios can be used in predicting the occurrence of biochemically incomplete response.

摘要

背景

对于甲状腺乳头状癌伴颈部淋巴结且生化反应不完全的患者,需要积极随访,临床反应预测指标将有助于更好地进行治疗和随访规划。

目的

确定淋巴结比率(中央区和侧区)作为全甲状腺切除术后及颈部清扫术后临床反应预测指标的效用。

材料与方法

51例甲状腺乳头状癌伴颈部淋巴结患者按照美国甲状腺协会(ATA)指南接受手术及放射性碘(RAI)治疗,并进行了中位时间为3年的分析。(回顾性队列分析)

结果

我们进行了反应评估,将临床反应与淋巴结比率相关联。我们发现淋巴结比率与生化反应不完全的预测之间存在统计学显著关系,敏感性和特异性约为90%。

结论

我们得出结论,侧区和中央区淋巴结比率可用于预测生化反应不完全的发生情况。